Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
85 hedge funds and large institutions have $120M invested in Gritstone bio, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 17 closing their positions.
24% more capital invested
Capital invested by funds: $97.1M → $120M (+$23.3M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 88 → 85 (-3)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
21% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 28
75% less call options, than puts
Call options by funds: $3.13M | Put options by funds: $12.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.28M |
| 2 |
AG
Artal Group
Luxembourg
|
+$2.52M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.64M |
| 4 |
Goldman Sachs
New York
|
+$830K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$809K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$10.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.2M |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$458K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$411K |
GRTS Hedge Fund Activity: Q1 2024 in Review
85 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q1 2024, worth a combined $120M — up 24% from $97.1M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of GRTS and 14 opened new positions — a net loss of 3 holders — while 28 trimmed existing stakes and 22 added.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $7.28M. The largest seller was Morgan Stanley, cutting an estimated $10.5M.
- 85 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q1 2024, down from 88 in Q4 2023.
- Funds reported $120M of Gritstone bio, Inc. Common Stock stock for Q1 2024, up 24% quarter-over-quarter.
- 14 funds opened new Gritstone bio, Inc. Common Stock positions in Q1 2024 and 17 closed out, a net change of -3 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q1 2024 was Deutsche Bank, an estimated $7.28M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $10.5M sold.
Based on aggregated 13F filings for Q1 2024.